MYNZEPLI 40mg/ml solution for injection in pre-filled syringe ADVANZ PHARMA LIMITE
aflibercept Indicated for: macular degeneration; diabetic macular edema
S01LA05 Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents
letter M · page 65
aflibercept Indicated for: macular degeneration; diabetic macular edema
S01LA05 Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents
doxorubicin Indicated for: cancer
doxorubicin Indicated for: cancer
tetrazepam Indicated for: spasticity; muscle spasms
Tc - tetrofosmin Indicated for: myocardial perfusion imaging
V09GA02 Various | Cardiovascular system | Technetium (99mtc) compounds
Tc - tetrofosmin Indicated for: myocardial perfusion imaging
V09GA02 Various | Cardiovascular system | Technetium (99mtc) compounds
Tc - tetrofosmin Indicated for: myocardial perfusion imaging
V09GA02 Various | Cardiovascular system | Technetium (99mtc) compounds
alpha glucosidase Indicated for: Pompe disease
sildenafil Indicated for: erectile dysfunction; pulmonary arterial hypertension
naltrexone + bupropion Indicated for: depression
lanreotide Indicated for: acromegaly; neuroendocrine tumors
lanreotide Indicated for: acromegaly; neuroendocrine tumors
lanreotide Indicated for: acromegaly; neuroendocrine tumors
ethinylestradiol + drospirenone Indicated for: contraception
drospirenone + ethinylestradiol Indicated for: contraception